Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Purpose
to validate a qualitative enzyme-linked immunoassay (EIA) for measurement of poliovirus population immunity in endemic countries and in countries at risk of importation worldwide
Division
Global Development
Date
October 2013
Region Served
GLOBAL
Committed amount
$178,067
Grant topic
Polio
Duration (months)
49
Grantee location
Atlanta, Georgia, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.